Creative Medical Technology (US:CELZ) — Company Overview, News & Financial Data
Creative Medical Technology develops regenerative medical applications using stem cell therapies for urology, neurology, orthopedics, and cardiology.
Creative Medical Technology
Creative Medical Technology (NASDAQ:CELZ) focuses on the development of regenerative medical applications aimed at treating conditions related to urology, neurology, orthopedics, and cardiology. Their comprehensive approach integrates novel stem cell therapies and biologics to advance the treatment of various diseases and injuries. With several significant projects underway, Creative Medical Technology is dedicated to leveraging state-of-the-art scientific discoveries to improve patient outcomes and quality of life. Their objectives are deeply rooted in innovation, with a strong commitment to research and development as the cornerstone of their strategy to address unmet medical needs.
Snapshot
Operations
Products and/or services of Creative Medical Technology
- Stem cell therapies for treating erectile dysfunction, offering hope for regaining sexual function.
- Immuno-stimulation therapy aimed at enhancing the body's natural defenses against various diseases.
- AmnioStem product, utilizing amniotic fluid stem cells to support tissue regeneration and healing.
- Epidural stimulation technology for recovery of motor functions in patients with spinal cord injuries.
- OvaStem therapy for treating premature ovarian failure, aimed at restoring ovarian function.
- Platelet-rich plasma (PRP) therapy, enhancing the body’s natural healing process in orthopedic conditions.
Creative Medical Technology executive team
- Mr. Timothy WarbingtonCo-Founder, Chairman, President & CEO
- Mr. Donald F. Dickerson MBASenior VP, CFO & Director